Tech Company Financing Transactions
Therorna Funding Round
Therorna, based in Beijing, secured $42 million from MSA Capital, 3H Health Investment and Cenova Capital.
Transaction Overview
Company Name
Announced On
6/20/2022
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series A
Investors
MSA Capital (Lead Investor) (Yu Zeng)
Sherpa Healthcare Partners (Changzu Cai)
Proceeds Purpose
The new funding, Therorna plans to accelerate the build-out of its technology platform and the development of its product pipeline, as well as the clinical trials, regulatory applications, and international collaborations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Building 18, Belen Industrial Park, Yard 9, Yongteng North R
Beijing, 100094
CHINA
Beijing, 100094
CHINA
Phone
Undisclosed
Website
Email Address
Overview
Thermona (Beijing) Biotechnology Co., Ltd. (Therorna Inc.) was established in April 2021 by a team of well-known domestic experts and senior returnee doctors. The company focuses on the research and application of circular RNA technology in the field of innovative drugs and innovative therapies, and has established a rich pipeline of new preventive and therapeutic drugs, dedicated to addressing unmet clinical needs for diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tang Xiaodong
Vice President
Yuna Chen
Browse more venture capital transactions:
Prev: 6/20/2022: INSTANDA venture capital transaction
Next: 6/20/2022: Platform.sh venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs